Albert Kim, MD, PhD

Neurosurgeon

Albert Kim

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Video thumbnail for Albert Kim, MD, PhD

Watch video on YouTube

Albert Kim, MD, PhD

4 mins

Washington University neurosurgeon Albert Kim, MD, PhD, discusses what brain tumor patients can expect from their extended care team at Siteman Cancer Center. Learn more about Dr. Kim: https://siteman.wustl.edu/doctor/kim-albert/

Explore the Brain Tumor Center at Siteman: https://siteman.wustl.edu/treatment/cancer-types/brain-tumor-center/

Learn more about how Siteman personalizes brain tumor treatment: https://siteman.wustl.edu/personalized-brain-tumor-treatment/

Learn more about how Siteman's innovations in brain tumor surgery are advancing treatment: https://siteman.wustl.edu/innovations-brain-tumor-surgery/

Clinical Expertise

Primary Academic Title

August A. Busch Jr. Distinguished Professor of Neurological Surgery, Director, The Brain Tumor Center, WashU Medicine

Board Certification

  • 2015: American Board of Neurological Surgeons

Training

  • 2003 - 2004: Intern, Neurosurgery/General Surgery, Harvard University, Boston, MA
  • 2004 - 2010: Resident and Chief Resident, Neurosurgery, Harvard University, Boston, MA
  • 2010 - 2011: Fellow, Cerebrovascular and Skull-base Surgery, Jackson Memorial Hospital, Miami, FL

Education

  • 2003: MD/PhD, New York University School of Medicine, New York City, NY

Research & Select Publications

Research Interest

Brain tumors, including skull-base tumors. Research interests include tumor microenvironments and advanced imaging of brain tumors.

Research Publications

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
Authors:

Garfinkle EAR, Perales-Linares R, Gimple RC, one or more additional authors omitted Kim AH, one or more additional authors omitted Johanns TM

Journal & Year:

Nat Cancer | 2026

Laser Interstitial Thermal Therapy for Brain Metastases: Imaging Guidelines for Clinical Trials and Practice
Authors:

Sanvito F, Haskell-Mendoza AP, Leuthardt EC, Kim AH, one or more additional authors omitted Fecci PE

Journal & Year:

Neuro-oncology | 2026

Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial
Authors:

Campian JL, Le SB, Ghiaseddin A, one or more additional authors omitted Kim AH, one or more additional authors omitted Tran DD

Journal & Year:

Nat Commun | 2026

Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma
Authors:

Li YD, Giles DA, Huang Y, one or more additional authors omitted Kim AH, one or more additional authors omitted Chheda MG

Journal & Year:

Nat Commun | 2026

Extrachromosomal DNA associates with nuclear condensates and reorganizes chromatin structures to enhance oncogenic transcription
Authors:

Taghbalout A, Tung CH, Clow PA, one or more additional authors omitted Kim AH, Wei CL

Journal & Year:

Cancer Cell | 2025

INSM1 governs a neuronal progenitor state that drives glioblastoma in a human stem cell model
Authors:

DeSouza PA, Ishahak M, Qu X, one or more additional authors omitted Kim AH

Journal & Year:

Nat Commun | 2025

Postoperative fluid restriction to prevent delayed hyponatremia after endoscopic transsphenoidal surgery
Authors:

Klaassen D, Mok S, Hwang JY, one or more additional authors omitted Kim AH, Silverstein JM

Journal & Year:

Neuro-oncology | 2025

Interstitial Thermal Therapy in Mesial Temporal Lobe Epilepsy
Authors:

Landazuri P, Cheng JJ, Leuthardt E, Kim AH, one or more additional authors omitted Baumgartner J

Journal & Year:

JAMA Neurol | 2025

NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomas
Authors:

Patel B, Pugazenthi S, English CW, one or more additional authors omitted Kim AH

Journal & Year:

J Natl Cancer Inst | 2025

Genetically Engineered Brain Organoids Recapitulate Spatial and Developmental States of Glioblastoma Progression
Authors:

Ishahak M, Han RH, Annamalai D, one or more additional authors omitted Kim AH, Millman JR

Journal & Year:

Adv Sci (Weinh) | 2025

Multiomic and clinical analysis of multiply recurrent meningiomas reveals risk factors, underlying biology, and insights into evolution
Authors:

Pugazenthi S, Patel B, English CW, one or more additional authors omitted Kim AH

Journal & Year:

Sci Adv | 2024

Tumour evolution and microenvironment interactions in 2D and 3D space
Authors:

Mo CK, Liu J, Chen S, one or more additional authors omitted Kim AH, one or more additional authors omitted Ding L

Journal & Year:

Nature | 2024

Epigenetic therapy potentiates transposable element transcription to create tumor-enriched antigens in glioblastoma cells
Authors:

Jang HJ, Shah NM, Maeng JH, one or more additional authors omitted Kim AH, Wang T

Journal & Year:

Nat Genet | 2024

Laser interstitial thermal therapy for new and recurrent meningioma: a prospective and retrospective case series
Authors:

Chiang VL, Pugazenthi S, Leidig WA, one or more additional authors omitted Kim AH

Journal & Year:

J Neurosurg | 2024

Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
Authors:

Johanns TM, Garfinkle EAR, Miller KE, one or more additional authors omitted Kim AH, one or more additional authors omitted Dunn GP

Journal & Year:

Clin Cancer Res | 2024